Molecularly Imprinted Nanomedicine for Anti-Angiogenic Cancer Therapy via Blocking Vascular Endothelial Growth Factor Signaling

The anti-VEGF nanomedicine was prepared via a state-of-the-art molecular imprinting approach using the N-terminal epitope of VEGF as the template.
[Nano Letters]
AbstractGraphical Abstract

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News